| 1 |
34327917 | [Immunomodulatory effect of adriamycin in mouse 4T1 model of breast cancer]. | 2021 Jul 25 |
1 |
| 2 |
32328672 | Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model. | 2020 Sep |
1 |
| 3 |
32551517 | Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy. | 2020 Jul 15 |
1 |
| 4 |
30831276 | Immunostimulatory cytokine and doxorubicin co-loaded nanovesicles for cancer immunochemotherapy. | 2019 Jun |
4 |
| 5 |
29744449 | DOX/IL-2/IFN-γ co-loaded thermo-sensitive polypeptide hydrogel for efficient melanoma treatment. | 2018 Mar |
1 |
| 6 |
29805796 | Thymoquinone Ameliorates Doxorubicin-Induced Cardiotoxicity in Swiss Albino Mice by Modulating Oxidative Damage and Cellular Inflammation. | 2018 |
2 |
| 7 |
30011369 | Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy. | 2018 Sep 4 |
1 |
| 8 |
23323011 | Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice. | 2012 Dec 21 |
1 |
| 9 |
21165950 | Antitumor activity of IL-2/anti-IL-2 mAb immunocomplexes exerts synergism with that of N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugate due to its low immunosuppressive activity. | 2011 Oct 15 |
2 |
| 10 |
18438341 | The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin. | 2008 Mar |
1 |
| 11 |
16806008 | [Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism]. | 2006 Jul |
1 |
| 12 |
15862144 | [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor]. | 2005 May |
1 |
| 13 |
15914329 | Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. | 2005 Jul |
1 |
| 14 |
16102261 | Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. | 2005 Aug |
2 |
| 15 |
12698271 | Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. | 2003 Jul |
2 |
| 16 |
11137614 | Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumors. | 2000 Dec |
2 |
| 17 |
10100723 | Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. | 1999 Mar |
3 |
| 18 |
8038458 | Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin-sensitive and -resistant lymphomas. | 1993 |
1 |
| 19 |
1622150 | Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanoma. | 1992 May-Jun |
1 |
| 20 |
3501452 | [Effects of cimetidine and PSK on interleukin-2 production by PBL in patients with advanced ovarian carcinoma during the course of chemotherapy]. | 1987 Nov |
1 |
| 21 |
3501806 | An immunochemotherapy protocol for enhanced tumoricidal activity: in vivo treatment with IL-2 prior to chemotherapy. | 1987 Oct |
1 |
| 22 |
3484381 | Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice. | 1986 Jan |
2 |